HYPERION DEFI, INC. Proceeds from Notes Payable
HYPERION DEFI, INC. (HYPD) reported Proceeds from Notes Payable of $5.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-11-12
- HYPERION DEFI, INC. proceeds from notes payable for the quarter ending 2023-09-30 was $0.00.
- HYPERION DEFI, INC. proceeds from notes payable for the quarter ending 2022-12-31 was $0.00.
- HYPERION DEFI, INC. proceeds from notes payable for the quarter ending 2022-09-30 was $0.00.
- HYPERION DEFI, INC. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00.
- HYPERION DEFI, INC. proceeds from notes payable for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HYPERION DEFI, INC. proceeds from notes payable for fiscal 2021 was $7.50M.
- HYPERION DEFI, INC. proceeds from notes payable for fiscal 2020 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.00M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $7.50M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $7.50M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $7.50M 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |